Tumor prevention and antitumor immunity with heat shock protein 70 induced by 15-deoxy-Δ12,14-prostaglandin J2 in transgenic adenocarcinoma of mouse prostate cells

Cancer Research

Volumn 60, Issue 17, 2000, Pages 4714-4718

  Vanaja, D K ^a   Grossmann, M E ^a   Celis, E ^a   Young, C Y F ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 70; PROSTAGLANDIN J2;

ANIMAL CELL; ARTICLE; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CANCER PREVENTION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; IMMUNE RESPONSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

ADENOCARCINOMA; ANIMALS; BIOLOGICAL RESPONSE MODIFIERS; CANCER VACCINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HSP70 HEAT-SHOCK PROTEINS; IMMUNITY, NATURAL; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROSTAGLANDIN D2; PROSTATIC NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0034282811     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Defective presentation of endogenous antigens by a murine sarcoma
2. Identification of human cancers deficient in antigen processing
3. Loss of transporter in antigen processing 1 transport protein and major histocompatibility complex class I molecules in metastatic versus primary breast cancer
4. Influence of gene modified (IL-7,IL-4 and B7) tumor cell vaccines on tumor antigen presentation
5. Protective and curative potential of vaccination with interleukin-2 gene-transfected cells from a spontaneous mouse mammary adenocarcinoma
6. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides
7. 2
8. 2
9. + T cells in vivo
10. Priming of T cells by heat shock protein-peptide complexes as the basis of tumor vaccines
11. Heat shock proteins come of age: Primitive functions acquire new roles in an adaptive world
12. Heat shock proteins and cancer imrnunotherapy
13. Serologically unique surface antigen of a rat hepatoma is also its tumor-associated transplantation antigen
14. Tumor rejection antigens of chemically induced sarcomas of inbred mice
15. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations
16. Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70
17. Heat shock protein-peptide complexes, reconstituted in vitro elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity
18. Preventive and therapeutic effect of tumor derived heat shock protein, gp96, in an experimental prostate cancer model
19. Prostate cancer in a transgenic mouse
20. Longitudinal cohort analysis of lethal prostate cancer progression in Transgenic mice
21. The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice
22. Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model
23. Interactive effects of triiodothyronine and androgens on prostate cell growth and gene expression
24. Purification of immunogenic heat shock protein 70 peptide complexes by ADP-affinity chromatography
25. The Lobound-Wistar rat model of prostate cancer
26. Animal models for the study of prostate carcinogenesis
27. Heat shock protein-peptide complexes as immunotherapy for human cancer
28. Heat shock protein 70-associated peptides elicit specific cancer immunity
29. Hsp72 mediated augmentation of MHC class I surface expression and endogenous antigen presentation
30. Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins Hsp70, Hsp90, gp96